List of Excipients in API suvorexant
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing suvorexant
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | BELSOMRA | suvorexant | 0006-0005 | CELLULOSE, MICROCRYSTALLINE | 2029-11-20 |
| Merck Sharp & Dohme LLC | BELSOMRA | suvorexant | 0006-0005 | COPOVIDONE K25-31 | 2029-11-20 |
| Merck Sharp & Dohme LLC | BELSOMRA | suvorexant | 0006-0005 | CROSCARMELLOSE SODIUM | 2029-11-20 |
| Merck Sharp & Dohme LLC | BELSOMRA | suvorexant | 0006-0005 | FERRIC OXIDE YELLOW | 2029-11-20 |
| Merck Sharp & Dohme LLC | BELSOMRA | suvorexant | 0006-0005 | FERROSOFERRIC OXIDE | 2029-11-20 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for suvorexant
Excipient focus: CELLULOSE, MICROCRYSTALLINE
suvorexant drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
suvorexant drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
suvorexant drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
suvorexant drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
suvorexant drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
suvorexant drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
suvorexant drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
suvorexant drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
suvorexant drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
suvorexant drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | suvorexant | 0006-0005 |
| >Company | >Ingredient | >NDC |
suvorexant drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
